Diabetes Advances Cardiomyocyte Senescence Through Interfering Rnd3 Expression and Function
Authors:
Open Access
- 2 March 2025
- journal article
- Published by Wiley in Aging Cell
- Vol. 24 (6) , e70031
Abstract
Rnd3 is a small Rho‐GTPase that has been implicated in various cardiovascular diseases. Yet, its role in diabetes‐induced cardiomyocyte senescence remains unknown. Here we tested the role of Rnd3 in cardiomyocyte senescence and diabetic cardiomyopathy (DCM). The expression of Rnd3 was found to be reduced in peripheral blood mononuclear cells from diabetic patients and correlated negatively with age but positively with cardiac function. In 96‐week‐old Sprague Dawley (SD) rats, cardiac function was impaired, accompanied by an increased number of SA‐β‐gal‐positive cells and elevated levels of the senescence‐associated secretory phenotype (SASP) related factors, compared to those of 12‐week‐old rats. Diabetes and high glucose (HG, 35 mmol/L D‐glucose) suppressed Rnd3 expression in cardiomyocytes and induced cardiomyocyte senescence. The deficiency of Rnd3 exacerbated cardiomyocyte senescence in vitro and in vivo. MicroRNA sequencing in AC16 cells identified a conserved miR‐103a‐3p (present in humans and rats) as a key HG‐upregulated microRNA that bound to the Rnd3 3′‐UTR. In cultured cardiomyocytes, miR‐103a‐3p inhibitors antagonized HG‐induced cardiomyocyte senescence dependent on Rnd3 expression. Treatment with AAV9 vectors carrying miR‐103a‐3p sponges and Rnd3 ‐overexpressing plasmids alleviated cardiomyocyte senescence and restored cardiac function in diabetic SD rats. HG stimulation increased STAT3 (Tyr705) phosphorylation and promoted its nuclear translocation in H9C2 cells, an effect exacerbated by Rnd3 knockout. Mechanistically, Rnd3 interacted with p‐STAT3 in the cytoplasm, facilitating proteasome‐mediated ubiquitination and p‐STAT3 degradation. The STAT3 inhibitor S3I‐201 blocked HG‐induced STAT3 activation and mitigated cardiomyocyte senescence. These findings suggest that diabetes induces cardiomyocyte senescence via the miR‐103a‐3p/Rnd3/STAT3 signaling pathway, highlighting a potential therapeutic target for DCM.Keywords
Funding Information
- National Natural Science Foundation of China (82060053)
- National Natural Science Foundation of China (82260083)
- National Natural Science Foundation of China (82170440)
- National Natural Science Foundation of China (U220A20270)
- Key Research and Development Project of Hainan Province (ZDYF2022SHFZ038)
- Key Research and Development Project of Hainan Province (ZDYF2020122)
This publication has 56 references indexed in Scilit:
- Mechanistic role of RND3-regulated IL33/ST2 signaling on cardiomyocyte senescenceLife Sciences, 2024
- Rnd3 suppresses endothelial cell pyroptosis in atherosclerosis through regulation of ubiquitination of TRAF6Clinical and Translational Medicine, 2023
- Noncoding RNAs in age-related cardiovascular diseasesAgeing Research Reviews, 2022
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Autophagy in the diabetic heart: A potential pharmacotherapeutic target in diabetic cardiomyopathyAgeing Research Reviews, 2021
- Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal disseminationCell Reports, 2021
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2019
- Exosome-mediated miR-200b promotes colorectal cancer proliferation upon TGF-β1 exposureBiomedicine & Pharmacotherapy, 2018
- Pathophysiological Functions of Rnd 3/ RhoE2015
- Mitomycin C induces fibroblasts apoptosis and reduces epidural fibrosis by regulating miR-200b and its targeting of RhoEEuropean Journal of Pharmacology, 2015